If you need more lookups,
subscriptions start at $34 USD/month.
Rob Dolski Location
Boston, MA, US
Rob Dolski Work
2023 -now Chief Financial Officer @
2022 -2023 Chief Financial Officer - Consultant @
2021 -2022 Chief Financial Officer @
2019 -2020 Vice President, Finance and Interim Principle Financial Officer @ Akcea Therapeutics (acquired by Ionis Pharmaceuticals in 2020)
2016 -2019 Vice President, Head of Financial Planning and Analysis @
2013 -2016 Senior Director, Finance @
2012 -2013 Vice President, Finance and Treasury @
2010 -2012 Executive Director, Financial Planning and Analysis @
2008 -2010 Senior Director, Financial Planning and Analysis @
2007 -2008 Director, Financial Planning and Analysis @
2005 -2007 Director of Finance @
2003 -2005 Senior Manager, Operations Finance @
2000 -2003 Manager, Corporate Business Analysis @
Rob Dolski Education
The Wharton School
MBA (Finance)
University of Pennsylvania
Rob Dolski Skills
Financial Analysis
Financial Reporting
Strategic Financial Planning
M&A experience
Business Development
Treasury Management
Portfolio Management
Lifesciences
Biotechnology
Corporate Development
Global Alliance Management
Strategic Partnerships
Cash Flow Forecasting
Business Planning
Strategy
Sarbanes-Oxley Act
Pharmaceutical Industry
Finance
Financial Modeling
Venture Capital
Investor Relations
Mergers & Acquisitions
Commercialization
Leadership
Budgets
Corporate Finance
Due Diligence
Cross-functional Team Leadership
Managerial Finance
Analysis
Valuation
Acquisition Integration
Forecasting
Biopharmaceuticals
Competitive Analysis
Executive Management
Start-ups
Product Management
Cost Accounting
Management
Financial Planning
Business Analysis
Cross Functional Team Leadership
Start Ups
Project Management
Strategic Planning
Mergers and Acquisitions
Sarbanes Oxley Act
Rob Dolski Summary
Rob Dolski, based in Boston, MA, US, is currently a Chief Financial Officer at Autolus Ltd.. Rob Dolski brings experience from previous roles at Odyssey Therapeutics, Checkmate Pharmaceuticals, Akcea Therapeutics (acquired by Ionis Pharmaceuticals in 2020) and Moderna Therapeutics. Rob Dolski holds a MBA in Finance @ The Wharton School. With a robust skill set that includes Financial Analysis, Financial Reporting, Strategic Financial Planning, M&A experience, Business Development and more. Rob Dolski has 3 emails and 4 mobile phone numbers on RocketReach.
Looking for a different Rob Dolski?
Find contact details for 700 million professionals.